Previous close | 0.7032 |
Open | 0.7160 |
Bid | 0.6605 x 1400 |
Ask | 0.6607 x 1300 |
Day's range | 0.6510 - 0.7500 |
52-week range | 0.4340 - 1.6200 |
Volume | |
Avg. volume | 19,395,114 |
Market cap | 249.013M |
Beta (5Y monthly) | 3.02 |
PE ratio (TTM) | N/A |
EPS (TTM) | -5.8100 |
Earnings date | 18 Sept 2023 - 22 Sept 2023 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 2.78 |
Aurora Cannabis (NASDAQ: ACB) shareholders are thirsty for some good news. Let's take a closer look at one of the new green flags worth knowing about with Aurora Cannabis as well as two relatively new red flags that could soon deepen the company's woes. The bright spot in Aurora's latest earnings release on Aug. 10 was its quarterly revenue, which shot up by 48% year over year, hitting $56 million.
You might be able to trade your investment for a few cups of coffee -- provided that you don't have expensive tastes.
Shares of cannabis companies Canopy Growth (NASDAQ: CGC) and Aurora Cannabis (NASDAQ: ACB) both plunged more than 10% in early trading Thursday morning. Canopy Growth quickly recovered most of its losses, and as of 10:30 a.m. ET today is only down about 1.8%. Aurora Cannabis didn't and is still down a depressing 7.2%.